SlideShare a Scribd company logo
1 of 1
Results
Extracellular vesicles (EVs) have been found in every body fluid
examined, but little is known about their abundance, cargo, or function in
cervicovaginal secretions (CVS). Previous work in our lab demonstrated
decreased particle concentrations in CVS of a rhesus macaque with
endometriosis compared with secretions of reproductively normal rhesus
and pigtailed macaques. For reliable interpretation of these data, more
information is needed on the influence of factors, including the menstrual
cycle (MC). In this study, we aimed to characterize changes in particle
count and RNA expression changes in EVs during MC in simian
immunodeficiency virus (SIV)-infected and uninfected rhesus macaques.
Nanoparticle Tracking Analysis (NTA) showed an increase in EV
concentration in the week following the progesterone peak in uninfected
macaques. SIV-infected macaques did not show any significant changes in
hormone levels across the five-week period, suggesting MC irregularities.
Similar findings for HIV have been sporadically reported in human, but
are unreported in the nonhuman primate literature.
Analysis of the miRNA from each fraction obtained during isolation of the
EVs, via TaqMan Low-Density Array (TLDA), revealed a significant
clustering of miRNA by fraction and at least one significantly upregulated
miR in the infected animal EVs as compared to the healthy controls.
Our initial results suggest that MC may affect EV concentration in CVS
and should be taken into account in future studies. Additional studies of
cervicovaginal EV and their RNA cargo are merited to further characterize
the potential role of EV and specific small RNAs as markers for any
manifestation of reproductive tract disease.
Abstract
Quantify the contribution of bacteria to EV counts through
bacterial RNA or outer membrane protein analysis.
Further investigate the pattern of EV particle concentration
fluctuation with different phases of the menstrual cycle.
In light of recent data demonstrating a inhibitory effect of
“exosomes” on an early stage of the HIV-1 life cycle, further
investigation into the mechanisms of miRNA regulation of in
vitro cultures is warranted
References
1. Witwer et al., 2013. Journal of extracellular vesicles
2. Ezechi et al., 2010. The Journal of Obstetrics and Gynaecology
Research.
3. Smith, J. A. & Daniel, R., 2016. AIDS.
Discussion / Further Directions
Results
Conclusions
• Hormonal data suggests that SIV-infected animals are likely not
experiencing regular menstrual cycle. There is evidence of
amenorrhea in humans associated with HIV2, but to our
knowledge this has not been reported in primate literature.
• There is encouraging preliminary nanoparticle concentration
data demonstrating a peak in particle concentration in the week
after the progesterone peak in the uninfected animals. These
results suggest that menstrual cycle may affect EV
concentration in cervicovaginal secretions and should be taken
into account in future studies.
• We have used TLDA to provide the first profile of miRNAs
from EVs from the CVL compartment.
• While only a handful of miRNA showed differential expression
in infected animals versus healthy controls from the EV fraction
(UCP), findings are consistent previous reports of upregulation
in people.
Objectives
• Collect samples of cervicovaginal secretions from SIV-infected and
healthy rhesus macaques.
• Determine changes in size and abundance of particles throughout the
menstrual cycle and between SIV-infected and healthy rhesus macaques
using nanoparticle tracking analysis.
• Characterize particles found in cervicovaginal secretions and vaginal
swabs using transmission electron microscopy.
• Profile miRNA from 10,000xg pellet (10K), 100000xg supernatant
(USN) and pellet (UCP)
• Determine how these data might affect measurements of EVs in donor
patients.
Methods
Sample Collection
Cervicovaginal lavage (CVL), and whole blood collection were performed weekly
for five weeks from two healthy, uninfected Rhesus macaques and four
SIVmac251-infected individuals.
Hormone Analysis
Platelet free plasma was analyzed for levels of estradiol and progesterone to
correlate particle counts with phase of MC.
EV visualization and concentration
Nanoparticle tracking analysis (NTA) was performed on whole CVL and EV
fractions enriched by stepped centrifugation. EV existence was verified with
Western Blot experiment using CD63 antibody.
Small RNA Evaluation
Total RNA was obtained from fractions using an optimized method for biofluids
RNA extraction. miRNAs from each fraction were profiled on a custom array by
TaqMan low density array (TLDA). Statistical analysis was done for the array data
and RT-qPCRs were performed to validate profiling results.
This research was supported by NIH NIDA R01-DA040385, NIH T32-
OD011089, the Johns Hopkins University Center for AIDS Research, an
NIH funded program (P30AI094189), and the Department of Molecular and
Comparative Pathobiology. The content is solely the responsibility of the
authors and does not necessarily represent the official views of the sponsors.
Contact: Zhao (zzhao23@jhu.edu), Muth (dillon.muth@jhmi.edu), Witwer
(kwitwer1@jhmi.edu)
Acknowledgements and funding:
B
CA
Results
A B C
Figure 4. Transmission electron micrographs of CVL pellet from 1000xg spin (A) and 110,000xg
spin (B). Images show EVs and rod-shaped bacteria with flagella. C) Western blot of 9 representative
samples from ultracentrifuged pellet. Significant smear for CD63 (34 kDA) noted for all but one
samples.
Figure 5. Multiple normalizations of TLDA data of all fractions of CVL data. Raw Cts, quantile
normalization and geometric means are all depicted. A) For Raw Ct values, significant cluster of the
UC Supernatant fraction is appreciable, indicating a greater presence of miRNA in that fraction for
almost all samples. A few animals partially cluster together across several weeks and sample
fractions, including Control 2 and Infected 2 and 3. No clustering of animal by infection status is
visible. No bias is present for week of collection, as all samples appear to be relatively well
distributed. B) A similar pattern is visible in data that has been normalized by quantiles. The UC
supernatant fraction clusters together again as in A), but unlike A) no animals appear to cluster
together. As in A) no pattern is appreciated for week of collection, menstruation status or infection
status. C) Using geometric mean normalization, the previously observed pattern of UC supernatant
clustering together is no longer present. Instead, the only small pattern that is noticed is a mild
clustering of three animals: Control 2, Infected 2 and Infected 4. In addition, no pattern by week of
collection, menstruation or infections status is present.
Figure 1. Specimen Collection Kit and Experimental layout. A) The kit used for collection of blood,
CVL and VS samples. CVL was performed with syringe containing 3mL and drawback was used to
collect wash. 2 cotton applicators were used in succession to swab the vaginal canal. Each swab was
placed in 2mL of 1x PBS and liberated per outlined protocol B) CVL and Swab 1 samples were
processed using differential ultracentrifugation to create EV enriched fractions. Portions of samples
were set aside for NanoSight analysis (NS) and RNA isolation as indicated. C) Workflow for
processing of samples.
A B Relative
AbundanceRank
onqPCR
miRNA Rankof relative
abundanceon
TLDA
1 223 1
2 16 3
3 222 2
4 19a 9
5 200c 4
6 186 6
7 181a 8
8 106a 5
9 125b 10
10 193b 7
11 451 11
12 375 N/A
Quantile
Normalization
Geometric
Mean
hsa-mir-222hsa-mir-200c
UC Pellet
hsa-mir-186
Infected vs. Uninfected
Figure 6. qPCR relative abundance verifies findings of TLDA array for UCP. A) Analysis of
both data normalized to a geometric mean of the 10 most invariant miRNA on the TLDA
profile and normalized by quantiles reals a consistent upregulation of mir-186. miR-200c and
miR-222 are also upregulated, but only appear so in each of the respective normalizations B)
Individual qPCR assays performed on all UC pellet samples reveals a profile of relative
abundance that is fairly similar to that seen on TLDA. The three highlighted miRNAs represent
those which had a significant ranking change (>3 ranks) on the list of 12 miRNAs for which
individual RT-qPCR was performed.
Figure 2. Progesterone concentrations compared to estradiol concentrations in weekly sample
collections in six rhesus macaques. Controls 1 and 2 are uninfected, while Infected 1-4 are
infected with SIV. Uninfected animals show characteristic patterns in estradiol and progesterone
levels suggestive of a regular menstrual cycle, while the SIV infected animals show no pattern in
hormone levels, suggesting a lack of regular menstrual cycle. Data points are duplicated for
second group of Week 1 to Week 5 to show trend.
W
eek
1
W
eek
2
W
eek
3
W
eek
4
W
eek
5
W
eek
1
W
eek
2
W
eek
3
W
eek
4
W
eek
5
0
100
200
300
400
0
1
2
3
EstradiolConcentration(pg/mL)
Theoretical Estradiol and Progesterone Concentrations
During Normal Menstrual Cycle
ProgesteroneConcentration(ng/mL)
W
eek
1
W
eek
2
W
eek
3
W
eek
4
W
eek
5
W
eek
1
W
eek
2
W
eek
3
W
eek
4
W
eek
5
0
50
100
150
200
250
0
1
2
3
4
5
EstradiolConcentration(pg/mL)
Control 1
ProgesteroneConcentration(ng/mL)
W
eek
1
W
eek
2
W
eek
3
W
eek
4
W
eek
5
W
eek
1
W
eek
2
W
eek
3
W
eek
4
W
eek
5
0
50
100
150
200
250
0
1
2
3
4
5
EstradiolConcentration(pg/mL)
Control 2
ProgesteroneConcentration(ng/mL)
W
eek
1
W
eek
2
W
eek
3
W
eek
4
W
eek
5
W
eek
1
W
eek
2
W
eek
3
W
eek
4
W
eek
5
0
50
100
150
200
250
0
1
2
3
4
5
EstradiolConcentration(pg/mL)
Infected 2
ProgesteroneConcentration(ng/mL)
W
eek
1
W
eek
2
W
eek
3
W
eek
4
W
eek
5
W
eek
1
W
eek
2
W
eek
3
W
eek
4
W
eek
5
0
50
100
150
200
250
0
1
2
3
4
5
EstradiolConcentration(pg/mL)
Infected 1
ProgesteroneConcentration(ng/mL)
W
eek
1
W
eek
2
W
eek
3
W
eek
4
W
eek
5
W
eek
1
W
eek
2
W
eek
3
W
eek
4
W
eek
5
0
50
100
150
200
250
0
1
2
3
4
5
EstradiolConcentration(pg/mL)
Infected 3
ProgesteroneConcentration(ng/mL)
W
eek
1
W
eek
2
W
eek
3
W
eek
4
W
eek
5
W
eek
1
W
eek
2
W
eek
3
W
eek
4
W
eek
5
0
50
100
150
200
250
0
1
2
3
4
5
EstradiolConcentration(pg/mL)
Infected 4
ProgesteroneConcentration(ng/mL)
W
eek
1
W
eek
2
W
eek
3
W
eek
4
W
eek
5
W
eek
1
W
eek
2
W
eek
3
W
eek
4
W
eek
5
0
2×109
4×109
6×109
0
1
2
3
4
5
Particles/mL
Control 1
ProgesteroneConcentration(pg/mL)
W
eek
1
W
eek
2
W
eek
3
W
eek
4
W
eek
5
W
eek
1
W
eek
2
W
eek
3
W
eek
4
W
eek
5
0
2×109
4×109
6×109
0
1
2
3
4
5
Particles/mL
Infected 1
ProgesteroneConcentration(pg/mL)
W
eek
1
W
eek
2
W
eek
3
W
eek
4
W
eek
5
W
eek
1
W
eek
2
W
eek
3
W
eek
4
W
eek
5
0
2×109
4×109
6×109
0
1
2
3
4
5
Particles/mL
Infected 3
ProgesteroneConcentration(pg/mL)
W
eek
1
W
eek
2
W
eek
3
W
eek
4
W
eek
5
W
eek
1
W
eek
2
W
eek
3
W
eek
4
W
eek
5
0
2×109
4×109
6×109
0
1
2
3
4
5
Particles/mL
Control 2
ProgesteroneConcentration(pg/mL)
W
eek
1
W
eek
2
W
eek
3
W
eek
4
W
eek
5
W
eek
1
W
eek
2
W
eek
3
W
eek
4
W
eek
5
0
2×109
4×109
6×109
0
1
2
3
4
5
Particles/mL
Infected 1
ProgesteroneConcentration(pg/mL)
W
eek
1
W
eek
2
W
eek
3
W
eek
4
W
eek
5
W
eek
1
W
eek
2
W
eek
3
W
eek
4
W
eek
5
0
2×109
4×109
6×109
0
1
2
3
4
5
Particles/mL
Infected 4
ProgesteroneConcentration(pg/mL)
Figure 3. Nanoparticle concentrations from ultra-centrifuged CVL samples show an
increase in particle concentration in the week of or the week following the progesterone
peak in the uninfected, cycling animals, with no pattern observed in the infected animals.
Data points are duplicated for second group of Week 1 to Week 5 to show trend.
Influence of menstrual cycle and retroviral infection on primate cervicovaginal
extracellular vesicles and RNA
Zezhou Zhao1, Dillon C. Muth1, Kathleen Mulka1, Lauren Ostrenga1, Bonita Powell1, Kelly A. Metcalf Pate1, Kenneth W. Witwer1,2
1Molecular and Comparative Pathobiology and 2Neurology, The Johns Hopkins University School of Medicine, USA

More Related Content

What's hot

BrandeisBiologyREUResearchPoster_final_final
BrandeisBiologyREUResearchPoster_final_finalBrandeisBiologyREUResearchPoster_final_final
BrandeisBiologyREUResearchPoster_final_final
Victor Suarez
 
Q biomarkersomaticmutation
Q biomarkersomaticmutationQ biomarkersomaticmutation
Q biomarkersomaticmutation
Elsa von Licy
 
Multiplex TaqMan Assays for Rare Mutation Analysis Using Digital PCR
Multiplex TaqMan Assays for Rare Mutation Analysis Using Digital PCRMultiplex TaqMan Assays for Rare Mutation Analysis Using Digital PCR
Multiplex TaqMan Assays for Rare Mutation Analysis Using Digital PCR
Thermo Fisher Scientific
 
Array_nmeth.3507
Array_nmeth.3507Array_nmeth.3507
Array_nmeth.3507
Aana Hahn
 

What's hot (20)

BrandeisBiologyREUResearchPoster_final_final
BrandeisBiologyREUResearchPoster_final_finalBrandeisBiologyREUResearchPoster_final_final
BrandeisBiologyREUResearchPoster_final_final
 
The expression of ITPK in normal colon and colorectal cancer cells - Presenta...
The expression of ITPK in normal colon and colorectal cancer cells - Presenta...The expression of ITPK in normal colon and colorectal cancer cells - Presenta...
The expression of ITPK in normal colon and colorectal cancer cells - Presenta...
 
The expression of ITPK in normal colon and colorectal cancer cells - Paper
The expression of ITPK in normal colon and colorectal cancer cells - PaperThe expression of ITPK in normal colon and colorectal cancer cells - Paper
The expression of ITPK in normal colon and colorectal cancer cells - Paper
 
The expression of ITPK in normal colon and colorectal cancer cells - Poster
The expression of ITPK in normal colon and colorectal cancer cells - PosterThe expression of ITPK in normal colon and colorectal cancer cells - Poster
The expression of ITPK in normal colon and colorectal cancer cells - Poster
 
Sales 2
Sales 2Sales 2
Sales 2
 
Tumor Mutational Load assessment of FFPE samples using an NGS based assay
Tumor Mutational Load assessment of FFPE samples using an NGS based assayTumor Mutational Load assessment of FFPE samples using an NGS based assay
Tumor Mutational Load assessment of FFPE samples using an NGS based assay
 
2017 BDSRA Berg CLN3
2017 BDSRA Berg CLN32017 BDSRA Berg CLN3
2017 BDSRA Berg CLN3
 
Characterizing the Microbiome of Neonates and Infants to explore associations...
Characterizing the Microbiome of Neonates and Infants to explore associations...Characterizing the Microbiome of Neonates and Infants to explore associations...
Characterizing the Microbiome of Neonates and Infants to explore associations...
 
Q biomarkersomaticmutation
Q biomarkersomaticmutationQ biomarkersomaticmutation
Q biomarkersomaticmutation
 
1110.full
1110.full1110.full
1110.full
 
Luis Velasquez Cumplido (Differences in the Endometrial)
Luis Velasquez Cumplido (Differences in the Endometrial)Luis Velasquez Cumplido (Differences in the Endometrial)
Luis Velasquez Cumplido (Differences in the Endometrial)
 
Multiplex TaqMan Assays for Rare Mutation Analysis Using Digital PCR
Multiplex TaqMan Assays for Rare Mutation Analysis Using Digital PCRMultiplex TaqMan Assays for Rare Mutation Analysis Using Digital PCR
Multiplex TaqMan Assays for Rare Mutation Analysis Using Digital PCR
 
New Research Evaluating Cisplatin Uptake in Ovarian Cancer Cells by Single Ce...
New Research Evaluating Cisplatin Uptake in Ovarian Cancer Cells by Single Ce...New Research Evaluating Cisplatin Uptake in Ovarian Cancer Cells by Single Ce...
New Research Evaluating Cisplatin Uptake in Ovarian Cancer Cells by Single Ce...
 
International Journal of Proteomics & Bioinformatics
International Journal of Proteomics & BioinformaticsInternational Journal of Proteomics & Bioinformatics
International Journal of Proteomics & Bioinformatics
 
Development and Validation of a Two-Site Immunoradiometric assay for Glypican...
Development and Validation of a Two-Site Immunoradiometric assay for Glypican...Development and Validation of a Two-Site Immunoradiometric assay for Glypican...
Development and Validation of a Two-Site Immunoradiometric assay for Glypican...
 
Building a Program in Personalized Medicine
Building a Program in Personalized Medicine Building a Program in Personalized Medicine
Building a Program in Personalized Medicine
 
Article_Subclones_BIG
Article_Subclones_BIGArticle_Subclones_BIG
Article_Subclones_BIG
 
Array_nmeth.3507
Array_nmeth.3507Array_nmeth.3507
Array_nmeth.3507
 
Identification of antibiotic resistance genes in Klebsiella pneumoniae isolat...
Identification of antibiotic resistance genes in Klebsiella pneumoniae isolat...Identification of antibiotic resistance genes in Klebsiella pneumoniae isolat...
Identification of antibiotic resistance genes in Klebsiella pneumoniae isolat...
 
Genomic evaluation of low-heritability traits: dairy cattle health as a model
Genomic evaluation of low-heritability traits: dairy cattle health as a modelGenomic evaluation of low-heritability traits: dairy cattle health as a model
Genomic evaluation of low-heritability traits: dairy cattle health as a model
 

Similar to CFAR Poster ZZDM FINAL

Poster_Epitope_mapping_of_persisting_EBV_infection_01
Poster_Epitope_mapping_of_persisting_EBV_infection_01Poster_Epitope_mapping_of_persisting_EBV_infection_01
Poster_Epitope_mapping_of_persisting_EBV_infection_01
Paul Von Hoegen
 
Seahorse Poster DOS (JJW Edits 6-15-15)
Seahorse Poster DOS (JJW Edits 6-15-15)Seahorse Poster DOS (JJW Edits 6-15-15)
Seahorse Poster DOS (JJW Edits 6-15-15)
Zach Swanson
 
Journal Club- Urinary cell mRNA profile and acute cellular rejection
Journal Club- Urinary cell mRNA profile and acute cellular rejection Journal Club- Urinary cell mRNA profile and acute cellular rejection
Journal Club- Urinary cell mRNA profile and acute cellular rejection
Wisit Cheungpasitporn
 
AmandaGallagherFinalPoster
AmandaGallagherFinalPosterAmandaGallagherFinalPoster
AmandaGallagherFinalPoster
Amanda Gallagher
 
Prevalence of Rota Virus Detection by Reverse TranscriptasePolymerase Chain R...
Prevalence of Rota Virus Detection by Reverse TranscriptasePolymerase Chain R...Prevalence of Rota Virus Detection by Reverse TranscriptasePolymerase Chain R...
Prevalence of Rota Virus Detection by Reverse TranscriptasePolymerase Chain R...
IOSRJPBS
 
Global Gene Expression Profiles from Breast Tumor Samples using the Ion Ampli...
Global Gene Expression Profiles from Breast Tumor Samples using the Ion Ampli...Global Gene Expression Profiles from Breast Tumor Samples using the Ion Ampli...
Global Gene Expression Profiles from Breast Tumor Samples using the Ion Ampli...
Thermo Fisher Scientific
 
Hofstetter PON1 meeting 2015 KOmice corrected
Hofstetter PON1 meeting 2015 KOmice correctedHofstetter PON1 meeting 2015 KOmice corrected
Hofstetter PON1 meeting 2015 KOmice corrected
Catherine A. Hofstetter
 
ACR2016 Wermuth Exosome poster
ACR2016 Wermuth Exosome posterACR2016 Wermuth Exosome poster
ACR2016 Wermuth Exosome poster
Kellan Carney
 
Vector delivery
Vector deliveryVector delivery
Vector delivery
zwiegers
 

Similar to CFAR Poster ZZDM FINAL (20)

Poster_Epitope_mapping_of_persisting_EBV_infection_01
Poster_Epitope_mapping_of_persisting_EBV_infection_01Poster_Epitope_mapping_of_persisting_EBV_infection_01
Poster_Epitope_mapping_of_persisting_EBV_infection_01
 
Seahorse Poster DOS (JJW Edits 6-15-15)
Seahorse Poster DOS (JJW Edits 6-15-15)Seahorse Poster DOS (JJW Edits 6-15-15)
Seahorse Poster DOS (JJW Edits 6-15-15)
 
Journal Club- Urinary cell mRNA profile and acute cellular rejection
Journal Club- Urinary cell mRNA profile and acute cellular rejection Journal Club- Urinary cell mRNA profile and acute cellular rejection
Journal Club- Urinary cell mRNA profile and acute cellular rejection
 
P 424
P 424P 424
P 424
 
AmandaGallagherFinalPoster
AmandaGallagherFinalPosterAmandaGallagherFinalPoster
AmandaGallagherFinalPoster
 
Prevalence of Rota Virus Detection by Reverse TranscriptasePolymerase Chain R...
Prevalence of Rota Virus Detection by Reverse TranscriptasePolymerase Chain R...Prevalence of Rota Virus Detection by Reverse TranscriptasePolymerase Chain R...
Prevalence of Rota Virus Detection by Reverse TranscriptasePolymerase Chain R...
 
Molecular screening assay must have sample adequacy control
Molecular screening assay must have sample adequacy controlMolecular screening assay must have sample adequacy control
Molecular screening assay must have sample adequacy control
 
Antibiotic-pathogen-biomarker screening by PCR must have SAC
Antibiotic-pathogen-biomarker screening by PCR must have SACAntibiotic-pathogen-biomarker screening by PCR must have SAC
Antibiotic-pathogen-biomarker screening by PCR must have SAC
 
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
 
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
 
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
LncRNA WARS2-IT1 Functions as an Oncogene and is Associated with Poor Outcome...
 
Global Gene Expression Profiles from Breast Tumor Samples using the Ion Ampli...
Global Gene Expression Profiles from Breast Tumor Samples using the Ion Ampli...Global Gene Expression Profiles from Breast Tumor Samples using the Ion Ampli...
Global Gene Expression Profiles from Breast Tumor Samples using the Ion Ampli...
 
Deep Sequencing Identifies Novel Circulating and Hepatic ncRNA Profiles in NA...
Deep Sequencing Identifies Novel Circulating and Hepatic ncRNA Profiles in NA...Deep Sequencing Identifies Novel Circulating and Hepatic ncRNA Profiles in NA...
Deep Sequencing Identifies Novel Circulating and Hepatic ncRNA Profiles in NA...
 
Williams.pnas
Williams.pnasWilliams.pnas
Williams.pnas
 
Hofstetter PON1 meeting 2015 KOmice corrected
Hofstetter PON1 meeting 2015 KOmice correctedHofstetter PON1 meeting 2015 KOmice corrected
Hofstetter PON1 meeting 2015 KOmice corrected
 
Univ bacteriav PCR Primer
Univ bacteriav PCR PrimerUniv bacteriav PCR Primer
Univ bacteriav PCR Primer
 
ACR2016 Wermuth Exosome poster
ACR2016 Wermuth Exosome posterACR2016 Wermuth Exosome poster
ACR2016 Wermuth Exosome poster
 
Analytical Validation of the Oncomine™ Comprehensive Assay v3 with FFPE and C...
Analytical Validation of the Oncomine™ Comprehensive Assay v3 with FFPE and C...Analytical Validation of the Oncomine™ Comprehensive Assay v3 with FFPE and C...
Analytical Validation of the Oncomine™ Comprehensive Assay v3 with FFPE and C...
 
Publication 3 - 3rd Author
Publication 3 - 3rd AuthorPublication 3 - 3rd Author
Publication 3 - 3rd Author
 
Vector delivery
Vector deliveryVector delivery
Vector delivery
 

CFAR Poster ZZDM FINAL

  • 1. Results Extracellular vesicles (EVs) have been found in every body fluid examined, but little is known about their abundance, cargo, or function in cervicovaginal secretions (CVS). Previous work in our lab demonstrated decreased particle concentrations in CVS of a rhesus macaque with endometriosis compared with secretions of reproductively normal rhesus and pigtailed macaques. For reliable interpretation of these data, more information is needed on the influence of factors, including the menstrual cycle (MC). In this study, we aimed to characterize changes in particle count and RNA expression changes in EVs during MC in simian immunodeficiency virus (SIV)-infected and uninfected rhesus macaques. Nanoparticle Tracking Analysis (NTA) showed an increase in EV concentration in the week following the progesterone peak in uninfected macaques. SIV-infected macaques did not show any significant changes in hormone levels across the five-week period, suggesting MC irregularities. Similar findings for HIV have been sporadically reported in human, but are unreported in the nonhuman primate literature. Analysis of the miRNA from each fraction obtained during isolation of the EVs, via TaqMan Low-Density Array (TLDA), revealed a significant clustering of miRNA by fraction and at least one significantly upregulated miR in the infected animal EVs as compared to the healthy controls. Our initial results suggest that MC may affect EV concentration in CVS and should be taken into account in future studies. Additional studies of cervicovaginal EV and their RNA cargo are merited to further characterize the potential role of EV and specific small RNAs as markers for any manifestation of reproductive tract disease. Abstract Quantify the contribution of bacteria to EV counts through bacterial RNA or outer membrane protein analysis. Further investigate the pattern of EV particle concentration fluctuation with different phases of the menstrual cycle. In light of recent data demonstrating a inhibitory effect of “exosomes” on an early stage of the HIV-1 life cycle, further investigation into the mechanisms of miRNA regulation of in vitro cultures is warranted References 1. Witwer et al., 2013. Journal of extracellular vesicles 2. Ezechi et al., 2010. The Journal of Obstetrics and Gynaecology Research. 3. Smith, J. A. & Daniel, R., 2016. AIDS. Discussion / Further Directions Results Conclusions • Hormonal data suggests that SIV-infected animals are likely not experiencing regular menstrual cycle. There is evidence of amenorrhea in humans associated with HIV2, but to our knowledge this has not been reported in primate literature. • There is encouraging preliminary nanoparticle concentration data demonstrating a peak in particle concentration in the week after the progesterone peak in the uninfected animals. These results suggest that menstrual cycle may affect EV concentration in cervicovaginal secretions and should be taken into account in future studies. • We have used TLDA to provide the first profile of miRNAs from EVs from the CVL compartment. • While only a handful of miRNA showed differential expression in infected animals versus healthy controls from the EV fraction (UCP), findings are consistent previous reports of upregulation in people. Objectives • Collect samples of cervicovaginal secretions from SIV-infected and healthy rhesus macaques. • Determine changes in size and abundance of particles throughout the menstrual cycle and between SIV-infected and healthy rhesus macaques using nanoparticle tracking analysis. • Characterize particles found in cervicovaginal secretions and vaginal swabs using transmission electron microscopy. • Profile miRNA from 10,000xg pellet (10K), 100000xg supernatant (USN) and pellet (UCP) • Determine how these data might affect measurements of EVs in donor patients. Methods Sample Collection Cervicovaginal lavage (CVL), and whole blood collection were performed weekly for five weeks from two healthy, uninfected Rhesus macaques and four SIVmac251-infected individuals. Hormone Analysis Platelet free plasma was analyzed for levels of estradiol and progesterone to correlate particle counts with phase of MC. EV visualization and concentration Nanoparticle tracking analysis (NTA) was performed on whole CVL and EV fractions enriched by stepped centrifugation. EV existence was verified with Western Blot experiment using CD63 antibody. Small RNA Evaluation Total RNA was obtained from fractions using an optimized method for biofluids RNA extraction. miRNAs from each fraction were profiled on a custom array by TaqMan low density array (TLDA). Statistical analysis was done for the array data and RT-qPCRs were performed to validate profiling results. This research was supported by NIH NIDA R01-DA040385, NIH T32- OD011089, the Johns Hopkins University Center for AIDS Research, an NIH funded program (P30AI094189), and the Department of Molecular and Comparative Pathobiology. The content is solely the responsibility of the authors and does not necessarily represent the official views of the sponsors. Contact: Zhao (zzhao23@jhu.edu), Muth (dillon.muth@jhmi.edu), Witwer (kwitwer1@jhmi.edu) Acknowledgements and funding: B CA Results A B C Figure 4. Transmission electron micrographs of CVL pellet from 1000xg spin (A) and 110,000xg spin (B). Images show EVs and rod-shaped bacteria with flagella. C) Western blot of 9 representative samples from ultracentrifuged pellet. Significant smear for CD63 (34 kDA) noted for all but one samples. Figure 5. Multiple normalizations of TLDA data of all fractions of CVL data. Raw Cts, quantile normalization and geometric means are all depicted. A) For Raw Ct values, significant cluster of the UC Supernatant fraction is appreciable, indicating a greater presence of miRNA in that fraction for almost all samples. A few animals partially cluster together across several weeks and sample fractions, including Control 2 and Infected 2 and 3. No clustering of animal by infection status is visible. No bias is present for week of collection, as all samples appear to be relatively well distributed. B) A similar pattern is visible in data that has been normalized by quantiles. The UC supernatant fraction clusters together again as in A), but unlike A) no animals appear to cluster together. As in A) no pattern is appreciated for week of collection, menstruation status or infection status. C) Using geometric mean normalization, the previously observed pattern of UC supernatant clustering together is no longer present. Instead, the only small pattern that is noticed is a mild clustering of three animals: Control 2, Infected 2 and Infected 4. In addition, no pattern by week of collection, menstruation or infections status is present. Figure 1. Specimen Collection Kit and Experimental layout. A) The kit used for collection of blood, CVL and VS samples. CVL was performed with syringe containing 3mL and drawback was used to collect wash. 2 cotton applicators were used in succession to swab the vaginal canal. Each swab was placed in 2mL of 1x PBS and liberated per outlined protocol B) CVL and Swab 1 samples were processed using differential ultracentrifugation to create EV enriched fractions. Portions of samples were set aside for NanoSight analysis (NS) and RNA isolation as indicated. C) Workflow for processing of samples. A B Relative AbundanceRank onqPCR miRNA Rankof relative abundanceon TLDA 1 223 1 2 16 3 3 222 2 4 19a 9 5 200c 4 6 186 6 7 181a 8 8 106a 5 9 125b 10 10 193b 7 11 451 11 12 375 N/A Quantile Normalization Geometric Mean hsa-mir-222hsa-mir-200c UC Pellet hsa-mir-186 Infected vs. Uninfected Figure 6. qPCR relative abundance verifies findings of TLDA array for UCP. A) Analysis of both data normalized to a geometric mean of the 10 most invariant miRNA on the TLDA profile and normalized by quantiles reals a consistent upregulation of mir-186. miR-200c and miR-222 are also upregulated, but only appear so in each of the respective normalizations B) Individual qPCR assays performed on all UC pellet samples reveals a profile of relative abundance that is fairly similar to that seen on TLDA. The three highlighted miRNAs represent those which had a significant ranking change (>3 ranks) on the list of 12 miRNAs for which individual RT-qPCR was performed. Figure 2. Progesterone concentrations compared to estradiol concentrations in weekly sample collections in six rhesus macaques. Controls 1 and 2 are uninfected, while Infected 1-4 are infected with SIV. Uninfected animals show characteristic patterns in estradiol and progesterone levels suggestive of a regular menstrual cycle, while the SIV infected animals show no pattern in hormone levels, suggesting a lack of regular menstrual cycle. Data points are duplicated for second group of Week 1 to Week 5 to show trend. W eek 1 W eek 2 W eek 3 W eek 4 W eek 5 W eek 1 W eek 2 W eek 3 W eek 4 W eek 5 0 100 200 300 400 0 1 2 3 EstradiolConcentration(pg/mL) Theoretical Estradiol and Progesterone Concentrations During Normal Menstrual Cycle ProgesteroneConcentration(ng/mL) W eek 1 W eek 2 W eek 3 W eek 4 W eek 5 W eek 1 W eek 2 W eek 3 W eek 4 W eek 5 0 50 100 150 200 250 0 1 2 3 4 5 EstradiolConcentration(pg/mL) Control 1 ProgesteroneConcentration(ng/mL) W eek 1 W eek 2 W eek 3 W eek 4 W eek 5 W eek 1 W eek 2 W eek 3 W eek 4 W eek 5 0 50 100 150 200 250 0 1 2 3 4 5 EstradiolConcentration(pg/mL) Control 2 ProgesteroneConcentration(ng/mL) W eek 1 W eek 2 W eek 3 W eek 4 W eek 5 W eek 1 W eek 2 W eek 3 W eek 4 W eek 5 0 50 100 150 200 250 0 1 2 3 4 5 EstradiolConcentration(pg/mL) Infected 2 ProgesteroneConcentration(ng/mL) W eek 1 W eek 2 W eek 3 W eek 4 W eek 5 W eek 1 W eek 2 W eek 3 W eek 4 W eek 5 0 50 100 150 200 250 0 1 2 3 4 5 EstradiolConcentration(pg/mL) Infected 1 ProgesteroneConcentration(ng/mL) W eek 1 W eek 2 W eek 3 W eek 4 W eek 5 W eek 1 W eek 2 W eek 3 W eek 4 W eek 5 0 50 100 150 200 250 0 1 2 3 4 5 EstradiolConcentration(pg/mL) Infected 3 ProgesteroneConcentration(ng/mL) W eek 1 W eek 2 W eek 3 W eek 4 W eek 5 W eek 1 W eek 2 W eek 3 W eek 4 W eek 5 0 50 100 150 200 250 0 1 2 3 4 5 EstradiolConcentration(pg/mL) Infected 4 ProgesteroneConcentration(ng/mL) W eek 1 W eek 2 W eek 3 W eek 4 W eek 5 W eek 1 W eek 2 W eek 3 W eek 4 W eek 5 0 2×109 4×109 6×109 0 1 2 3 4 5 Particles/mL Control 1 ProgesteroneConcentration(pg/mL) W eek 1 W eek 2 W eek 3 W eek 4 W eek 5 W eek 1 W eek 2 W eek 3 W eek 4 W eek 5 0 2×109 4×109 6×109 0 1 2 3 4 5 Particles/mL Infected 1 ProgesteroneConcentration(pg/mL) W eek 1 W eek 2 W eek 3 W eek 4 W eek 5 W eek 1 W eek 2 W eek 3 W eek 4 W eek 5 0 2×109 4×109 6×109 0 1 2 3 4 5 Particles/mL Infected 3 ProgesteroneConcentration(pg/mL) W eek 1 W eek 2 W eek 3 W eek 4 W eek 5 W eek 1 W eek 2 W eek 3 W eek 4 W eek 5 0 2×109 4×109 6×109 0 1 2 3 4 5 Particles/mL Control 2 ProgesteroneConcentration(pg/mL) W eek 1 W eek 2 W eek 3 W eek 4 W eek 5 W eek 1 W eek 2 W eek 3 W eek 4 W eek 5 0 2×109 4×109 6×109 0 1 2 3 4 5 Particles/mL Infected 1 ProgesteroneConcentration(pg/mL) W eek 1 W eek 2 W eek 3 W eek 4 W eek 5 W eek 1 W eek 2 W eek 3 W eek 4 W eek 5 0 2×109 4×109 6×109 0 1 2 3 4 5 Particles/mL Infected 4 ProgesteroneConcentration(pg/mL) Figure 3. Nanoparticle concentrations from ultra-centrifuged CVL samples show an increase in particle concentration in the week of or the week following the progesterone peak in the uninfected, cycling animals, with no pattern observed in the infected animals. Data points are duplicated for second group of Week 1 to Week 5 to show trend. Influence of menstrual cycle and retroviral infection on primate cervicovaginal extracellular vesicles and RNA Zezhou Zhao1, Dillon C. Muth1, Kathleen Mulka1, Lauren Ostrenga1, Bonita Powell1, Kelly A. Metcalf Pate1, Kenneth W. Witwer1,2 1Molecular and Comparative Pathobiology and 2Neurology, The Johns Hopkins University School of Medicine, USA